Insulin Treatment, Type 2 Diabetes and Obesity
نویسندگان
چکیده
منابع مشابه
Exenatide therapy in insulin-treated type 2 diabetes and obesity.
BACKGROUND Exenatide, a GLP-1 analogue, is used in combination with oral anti-diabetic agents in type 2 diabetes and obesity, and promotes weight loss. Exenatide use in combination with insulin in insulin-treated type 2 diabetes and obesity is unlicensed in the UK and outcomes are unclear. AIMS To assess the effectiveness of exenatide in insulin-treated type 2 diabetes with obesity. DESIGN ...
متن کاملObesity, insulin resistance, and the pathway to type 2 diabetes
The increase in obesity in the U.S. and elsewhere can be explained by a variety of factors, as outlined by David Allison and his colleagues. Not only is the fast food diet a factor, but also are changes in ambient temperature, obesity-causing psychoactive molecules, associative sorting, changes in smoking habits, and reduction in sleep. In particular is the increase in visceral fat, which is as...
متن کاملInsulin-mediated sympathoexcitation in obesity and type 2 diabetes.
9. Babbs C, Warnes TW, Torrance HB, Ballardie FW. IgA nephro17. Lomax-Smith JD, Zabrowarny LA, Howarth GS, Seymour pathy in non-cirrhotic portal hypertension. Gut 1990; 32: AAE, Woodroffe AJ. The immunochemical characterisation of 225–226 mesangial IgA deposits. Am J Pathol 1983; 113: 359–364 10. Berger J, Yaneva H, Nabarra B. Glomerular changes in patients 18. Giron JA, Alvarez-Mon M, Menéndez...
متن کاملType 2 diabetes mellitus in childhood: obesity and insulin resistance.
As rates of childhood obesity climb, type 2 diabetes mellitus has increasingly been diagnosed in children and adolescents, with the highest incidence occurring among youth from racial and ethnic minority backgrounds. The serious complications associated with type 2 diabetes mellitus make it essential for physicians to be aware of risk factors and screening guidelines, allowing for earlier patie...
متن کاملEarly Insulin Treatment in Type 2 Diabetes
T he prevalence of diabetes in the world is growing at an unprecedented rate and rapidly becoming a health concern and burden in both developed and developing countries (1). In addition, we are now witnessing an upsurge in the incidence of type 2 diabetes in children and adolescents, with the potential of translating into a future catastrophic disease burden as vascular complications of the dis...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Research in Diabetes & Obesity Journal
سال: 2017
ISSN: 2476-1435
DOI: 10.19080/crdoj.2017.04.555649